2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$38.10+$0.04 (+0.11%)
Price as of Aug 03, 2026 8:30 AM EDT- $3.0BMarket Cap
- 71.52%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$38.10+$0.04 (+0.11%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.06 | ||
Change | -$0.42 (-1.10%) | ||
Open | $38.50 | ||
High | $38.65 | ||
Low | $37.15 | ||
Previous Close | $38.48 | ||
Volume | 875,347 | ||
30-Day Average Volume | 952,417 | ||
1-Week Change | 7.88% | ||
1-Month Change | 2.28% | ||
1-Year Change | 71.52% | ||
3-Year Change | 7.64% | ||
5-Year Change | -13.01% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $511.3M | ||
Market Cap | $3.0B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $15,000.00 | ||
Net Income | -$78.7M | ||
Free Cash Flow | -$67.2M | ||
EBIT | -$78.7M | ||
EBITDA | -$77.8M | ||
Net Working Capital | $407.8M | ||
EPS | -$1.18 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | 196,779 | ||
P/B | 7 | ||
P/E | -32 | ||
PEG | 0 | ||
Price/Free Cash Flow | -44 | ||
Price/Operating Cash Flow | -46 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue